Nir Zontag

Mr. Nir Zontag

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2025 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
NZNir Zontag
Nir Zontag
RSRon Skorochod
Ron Skorochod
YWYoram Wolf
Yoram Wolf
Background: Serotonergic antidepressants have been associated with an increased risk of weight gain. Because being overweight is strongly linked to macromastia development, which is a primary indication for breast reduction, it is very important to assess whether these medications pose the risk of postoperative complications. Objectives: The aim of this study was to evaluate the association between preoperative serotonergic antidepressant use and the incidence of postoperative complications following breast reduction. Methods: A retrospective cohort analysis was conducted using the TriNetX Global Collaborative Network. Female patients >18 years old who underwent breast reduction were divided into 2 groups: those with documented serotonergic antidepressant use prior to surgery and those with no history of serotonergic antidepressant use. Propensity score matching was applied to balance demographic and clinical variables. Primary outcomes included postoperative complications at 3 time intervals: 30 days, 60 days, and 90 days. Secondary outcomes included long-term complications after 1 and 2 years. Results: After 1:1 propensity score matching, each cohort consisted of 8625 patients. Within 30 days following breast reduction, patients in the serotonergic cohort had a significantly increased risk of surgical site infection (risk ratio [RR], 1.42; P = .003), wound dehiscence (RR, 1.524; P < .0001), inpatient hospitalization (RR, 1.375; P = .004), opioid use (1.474, P < .0001), and any surgical site complication (1.28, P < .0001) compared with the control cohort. These elevated risks persisted at 60 and 90 days postsurgery. For long-term outcomes, similar rates were noted after 1 and 2 years. Conclusions: Serotonergic antidepressant use is associated with an increased risk of short-term postoperative complications following breast reduction surgery. Level of Evidence: 2 (Therapeutic):

14 January 2026 in Aesthetic Surgery Journal Open Forum
Verified
Journal Article
Open access
YWYoram Wolf
Yoram Wolf
JZJonathan Zontag
Jonathan Zontag
RSRon Skorochod
Ron Skorochod
NZNir Zontag
Nir Zontag
Background: Abdominoplasty is a common procedure, especially among patients with obesity, a group in which proton pump inhibitor (PPI) use is highly prevalent. Although there are growing concerns regarding PPI-related complications, there is a lack of data on their effects in aesthetic surgery. Objectives: This study aims to assess the association between preoperative use of PPIs and the risk of short-term postoperative complications after abdominoplasty. Methods: This multicenter cohort study used the TriNetX Global Collaborative Network. Individuals aged 18 years or older who had abdominoplasty were identified and categorized into 2 groups based on preoperative PPI exposure: patients with a documented prescription before surgery and those without any recorded history of PPI prescription. To reduce baseline differences between groups, propensity score matching was conducted to achieve balance in demographic and clinical characteristics. Postoperative outcomes focused on complication rates evaluated at 30, 60, and 90 days after surgery. Results: After 1:1 propensity score matching, both groups comprised 2031 patients each. At 30 days following abdominoplasty, patients who received PPIs before surgery exhibited significantly higher risks of surgical-site infections (risk ratio [RR] 2.467; 95% CI, 1.358-4.48), wound dehiscence (RR 2; 95% CI, 1.079-3.706), opioid prescription (RR 1.368; 95% CI, 1.269-1.475), and any surgical-site complications (RR 2.545; 95% CI, 1.806-3.588) compared with the control group. These risks persisted at 60 and 90 days postsurgery. Conclusions: Preoperative exposure to PPIs may increase the risk of short-term postoperative complications following abdominoplasty. Additional studies are needed to define clinical guidelines regarding the perioperative management of these medications. Level of Evidence:3 (Therapeutic):

15 October 2025 in Journal of American Association for Pediatric Ophthalmology and Strabismus
Verified
Journal Article
Closed access
NZNir Zontag
Nir Zontag
JPJacob Perkins
Jacob Perkins
BWBrittany M. Wong
Brittany M. Wong
ALAlex V. Levin
Alex V. Levin

14 January 2026 in Aesthetic Surgery Journal Open Forum
Verified
Journal Article
Open access
NZNir Zontag
Nir Zontag
RSRon Skorochod
Ron Skorochod
YWYoram Wolf
Yoram Wolf
Gender-affirming surgeries (GASs) serve as a fundamental treatment for gender dysphoria, with growing evidence of their benefits in both health outcomes and quality of life. The aim of this study was to identify and analyze the 100 most-cited articles in the field, to highlight impactful studies, research trends, and prominent authors. A search of the Web of Science database was conducted to identify the top 100 most-cited articles related to GAS. Bibliometric and visual analyses were performed using VOSviewer, Bibliometrix, and Biblioshiny packages for R statistical software. The authors gathered and analyzed citation metrics, institutional networks, collaboration clusters, thematic keyword analysis, and author demographics. The 100 most-cited articles on GAS were published between 1980 and 2023, with an increase in both publication and citations after 2015. The thematic analysis demonstrated 2 primary research domains which focused on patient quality of life and surgical outcomes. The research institutions Vrije Universiteit Amsterdam, Johns Hopkins, and Ghent University led the field with Bouman and Mullender being among the most productive authors. The United States, together with the Netherlands emerged as dominant research centers with collaborative networks. Most studies were observational and reviews, with a mean evidence level of 3.05 and published primarily in Journal of Sexual Medicine and Plastic and Reconstructive Surgery. This first analysis of the 100 most-cited articles in the field of GAS highlights prominent authors, trends in research themes, and dominant geographic regions. Continued comprehensive bibliometric reviews are a necessity to guide future research and clinical practice. Level of Evidence: 5 (Therapeutic)

28 January 2026 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
NZNir Zontag
Nir Zontag
RSRon Skorochod
Ron Skorochod
YWYoram Wolf
Yoram Wolf
Background: Non-tobacco nicotine dependence has been recently linked to the obese population. Although abdominoplasty and panniculectomy are mainly indicated for patients with a history of obesity, no studies have yet investigated whether non-tobacco nicotine dependence poses a risk for abdominoplasty and panniculectomy complications. Objectives: The aim of this study was to evaluate the association between preoperative non-tobacco nicotine dependence and the incidence of postoperative complications following abdominoplasty and panniculectomy procedures. Methods: A retrospective cohort analysis was conducted based on data from the TriNetX Global Collaborative Network. Patients > 18 years who underwent abdominoplasty or panniculectomy were divided into 2 groups: those who had documented non-tobacco nicotine dependence (NTND) and those who had no documented nicotine dependence. Two subanalyses were further conducted, 1 of patients who underwent abdominoplasty and another of patients who underwent panniculectomy. Propensity score matching (PSM) was applied to balance demographic and clinical variables. Primary outcomes included postoperative complications at 3 time intervals: 30 days, 60 days, and 90 days. Results: After 1:1 PSM, each cohort consisted of 1116 patients. Within 90 days following abdominoplasty or panniculectomy, patients with NTND exhibited significantly higher risks of surgical site infection (relative risk [RR] 1.458, 95% CI: 1.093-1.945), readmission (RR 1.632, 95% CI: 1.099-2.422), inpatient hospitalization (RR 1.333, 95% CI: 1.028-1.73), postoperative opioid use (RR 1.281, 95% CI: 1.204-1.363), and any surgical site complications (RR 1.549, 95% CI: 1.287-1.865) compared to patients without nicotine dependence. Conclusions: Non-tobacco nicotine dependence is associated with increased risk of surgical site complications, readmission, and opioid consumption within 90 days postoperatively. Screening for NTND is required during preoperative consultations, and strategies aimed at mitigating the negative effect must be considered. Level of Evidence: 3: For image description, please refer to the figure legend and surrounding text.

Verified
Journal Article
Open access
PDF file
RSRon Skorochod
Ron Skorochod
NZNir Zontag
Nir Zontag
YWYoram Wolf
Yoram Wolf
Background: Body contouring surgery is a critical aspect of reconstructive and esthetic care, addressing both functional and psychosocial needs. As the global prevalence of obesity and related metabolic disorders is constantly on the rise, it is inevitable that patients presenting for body contouring procedures would display comorbid cardiometabolic conditions that can negatively impact surgical outcomes. Clustered cardiometabolic abnormalities have been linked to increased rates of surgical complications, medical adverse events, prolonged hospitalization, and need for revision procedures. However, its impact on body contouring surgery outcomes remains insufficiently characterized. Materials and Methods: TriNetX Global Collaborative Network, comprising deidentified electronic medical records from over 170 healthcare organizations was utilized for this study. Adults undergoing body contouring surgery were stratified by the presence of a composite cardiometabolic burden, defined as the combination of obesity, diabetes mellitus and hypertension, in the year preceding surgery. Cohorts were matched 1:1 using propensity score matching based on baseline demographics, comorbidities, and substance use. Risk ratios with 95% confidence intervals were calculated, with statistical significance set at p < 0.05. Outcomes were assessed at 30, 60, and 90 days postoperatively. Results: Among 188,164 body contouring patients, 6892 with composite cardiometabolic burden were propensity score–matched to controls. The study group was associated with significantly higher wound complications, surgical site infections, antibiotic use, and emergency department visits at 30, 60, and 90 days postoperatively, with no difference in hypertrophic scarring. Conclusions: Composite cardiometabolic burden, as defined in the study, demonstrated a significantly increased risk of adverse events following body contouring surgery, including wound-related morbidity, surgical site infection and increased healthcare utilization. These risks are evident from the early postoperative period and persist through at least the first 90 days after the procedure.